• 18 May 2021

    Our new COO: Silvy van Tuijl!

    Silvy is a seasoned executive, with extremely valuable experience in scaling a science-driven start-up, and an experienced scientist as well. From the 1st of May on, she will employ those […]

    Read more
    Read more about Our new COO: Silvy van Tuijl!
  • 8 April 2021

    Interview with ReportersOnline

    Recently our founder and CEO, Sander van Asbeck, was interviewed by Jan Taco te Gussinklo for ReportersOnline. In this article, they discussed the role of mRNA in the near and […]

    Read more
    Read more about Interview with ReportersOnline
  • 5 April 2021

    RiboPro officially 1 year!

    On the second of April 2021, RiboPro is officially 1 year old and that is cause for celebration. Especially, since we started during a difficult time, in which lab-access, funding […]

    Read more
    Read more about RiboPro officially 1 year!
  • 23 March 2021

    RiboPro raises €1.2M to become leader in (m)RNA

    Monday 22 March 2021, Oss, the Netherlands – RiboPro announced it has successfully closed a funding round of €1.2 million, led by Stichting Vlasroot, with a consortium of BOM, Rockstart […]

    Read more
    Read more about RiboPro raises €1.2M to become leader in (m)RNA
  • 18 March 2021

    RiboPro launches new website

    Today, the 18th of March, we launch our new website. With this website, we will build a center of knowledge on mRNA, readily available to our customers. In addition, we […]

    Read more
    Read more about RiboPro launches new website
  • 12 March 2021

    New products – Launch of RNAse-testing service

    RNAses are a major concern for everyone working with messenger RNA, since minor contamination with RNAse can quickly compromise the mRNA in your sample or application. When ordering mRNA from […]

    Read more
    Read more about New products – Launch of RNAse-testing service
  • 3 March 2021

    RiboPro receives MIT feasibility grant

    Project details RoboPro provides academic and industrial parties with high-quality messenger RNA for research and development. For most applications, the RNA structure needs the rest of the article.

    Read more
    Read more about RiboPro receives MIT feasibility grant